Reclassification of asymptomatic beta cell autoimmunity: a critical perspective

Diabetologia

Volumn 60, Issue 1, 2017, Pages 39-42

  Knip, Mikael ^a,b,c,d   Selvenius, Jenni ^c   Siljander, Heli ^a,b   Veijola, Riitta ^e  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d FOLKHÄLSAN RESEARCH CENTER   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Clinical science; Human; Prediction and prevention

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER;

ARTICLE; ASYMPTOMATIC DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHILD; COMPARATIVE STUDY; DISEASE CLASSIFICATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; METABOLISM; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; FEMALE; GLUCOSE INTOLERANCE; IMMUNOLOGY; MALE; PHYSIOLOGY;

AUTOANTIBODIES; AUTOIMMUNITY; CHILD; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN-SECRETING CELLS; MALE;

EID: 84992697224     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-4147-5     Document Type: Article

References (15)

1. Bonifacio E, Mathieu C, Nepom G et al (2016) Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity. Diabetologia doi:10.1007/s00125-016-4144-8
2. Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309:2473–2479
3. Vehik K, Lynch KF, Schatz DA et al (2016) Reversion of β-cell autoimmunity changes risk of type 1 diabetes: TEDDY study. Diabetes Care 39:1535–1542
4. Baker A, Carrier DJ, Schaedler T, Waterham HR, van Roermund CW, Theodoulou FL (2015) Peroxisomal ABC transporters: functions and mechanism. Biochem Soc Trans 43:959–965
5. Knip M, Korhonen S, Kulmala P et al (2010) Prediction of type 1 diabetes in the general population. Diabetes Care 33:1206–1212
6. Insel RA, Dunne JL, Atkinson MA et al (2015) Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38:1964–1974
7. Elding Larsson H, Vehik K, Bell R et al (2011) Reduced prevalence of diabetes ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care 34:2347–2352
8. Elding Larsson H, Vehik K, Gesualdo P et al (2014) Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr Diabetes 15:118–126
9. Bennett Johnson S (2011) Psychological impact of screening and prediction in type 1 diabetes. Curr Diab Rep 11:454–459
10. Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet. doi:10.1016/S0140-6736(16)30173-8
11. In’t Veld P, Lievens D, De Grijse J et al (2007) Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56:2400–2404
12. Wiberg A, Granstam A, Ingvast S et al (2015) Characterization of human organ donors testing positive for type 1 diabetes-associated autoantibodies. Clin Exp Immunol 182:278–288
13. Helminen O, Aspholm S, Pokka T et al (2015) HbA1c predicts time to diagnosis of type 1 diabetes in children at risk. Diabetes 64:1719–1727
14. Helminen O, Aspholm S, Pokka T et al (2015) Oral glucose tolerance test and random plasma glucose in prediction of type 1 diabetes. Diabetologia 58:1787–1796
15. World Health Organization (2006) Summary of technical report and recommendations. In: WHO, Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. WHO, Geneva, pp 1–3